How to build a closing deliverables checklist for Seed Equity Financing Rounds

Build the company’s seed equity closing checklist from the controlling purchase agreement, charter, ancillary agreements, corporate approvals, and conversion instruments—not a generic signature list. Give each item a source citation, named owner and reviewer, dependency, acceptance evidence, and release status. Separate initial-closing conditions, subsequent-closing requirements, and post-closing handoffs. The resulting checklist should show company counsel what is ready, what remains blocked, who can resolve each blocker, and what evidence supports releasing signatures, accepting funds, and recording the issuance.

When to use this workflow

Use this workflow when company counsel or the in-house legal team has a sufficiently settled seed preferred equity package to identify closing requirements. Start before collecting signatures: approval language, conversion calculations, purchaser allocations, and charter dependencies can change the package.

The scope is closing readiness and evidence, not a complete diligence exercise or ongoing compliance calendar. Carry unresolved diligence findings forward only when they affect a condition, deliverable, waiver, or agreed undertaking. A SAFE-only fundraising requires a different checklist; here, SAFEs and notes matter principally as instruments converting into the equity round.

This guide uses a US private company incorporated in Delaware as its corporate-law baseline. Other entities require different analysis. Securities exemptions, state notices, foreign-investment issues, and regulated-business requirements need deal-specific treatment. Contract rights depend on the documents, governing law, and facts; the workflow recommendations below are not independent legal requirements.

What you need

Collect the following working set, identifying controlling versions and execution status:

• Purchase agreement, purchaser allocation exhibit, disclosure schedules, proposed charter, investor rights agreement, voting or stockholders’ agreement, and side letters.
• Existing charter and governance documents, proposed board and stockholder approvals, existing investor consent rights, and delegated issuance authority, if relevant.
• Stock ledger, pre- and post-closing capitalization models, option and warrant records, SAFEs, notes, amendments, and conversion calculations.
• Closing instructions, signature contacts, certificates, filing arrangements, funding details, and negotiated undertakings or waivers.
• Counsel’s exemption analysis and evidence needed to identify filing triggers, including when investors become irrevocably committed.

Assign persistent document IDs such as PA-07 and CHAR-04. Preserve superseded versions separately so checklist citations cannot silently point to replacement documents. Obtain the operative conversion instruments rather than relying on a spreadsheet’s description. Identify who controls final document assembly, signature release, funding confirmation, and stock-record updates.

Use the template

Seed Equity Financing Rounds — Closing deliverables checklist

You can copy this table into your working document or spreadsheet. Create one row per independently verifiable deliverable, condition, or release decision.

Use ID / phase to distinguish initial closing, subsequent closing, and post-closing handoff. In Source / beneficiary, record the document ID, version, subsection or page, and condition beneficiary. Mark an organizational recommendation as “workflow,” not contractual.

Name the responsible preparer and reviewer in Owner; reviewer → recipient. Reference another checklist row in Dependency where possible. Required evidence states what closes the item: an executed consent, evidence establishing charter effectiveness, verified funds receipt, or an approved reconciliation—not simply “document received.”

Keep Status / gap factual: not started, pending evidence, blocked, verified, or waived. Use Decision / timing for the authorized disposition, target event, and final evidence location. A condition may need several supporting delivery rows, but designate one parent row for the satisfaction decision. “Waived” should point to waiver evidence, not imply performance.

Step by step

1. Fix the transaction perimeter and version baseline

Confirm the issuing entity, security, participating investors, and whether cash purchases and conversions occur together. Distinguish investors participating now from those expected at a subsequent closing. Identify any contractual limits or additional requirements governing that later closing rather than carrying forward the initial checklist unchanged.

List controlling versions and unresolved changes affecting deliverables. Reconcile purchaser names across signature pages, allocations, conversion records, and funding instructions. Verify the proposed record holder rather than copying a trade name from correspondence.

Record: A baseline row identifying the closing, document set, responsible reviewer, and unresolved version questions. Link later rows to this baseline so citations remain consistent.

2. Extract both sides’ conditions and required deliveries

Read company and purchaser conditions separately, together with delivery provisions and exhibits. Identify each condition’s beneficiary, applicable closing, required action, waiver mechanism, and satisfaction evidence.

As a drafting illustration, the filed Defeye purchase agreement separates initial purchaser conditions in Section 4 from company conditions in Section 5. Section 4 addresses representation accuracy, performance, certificates, stockholders’ agreement signatures, and an effective filed charter, and allows waiver. These are example-specific terms, not universal seed requirements. See Defeye, Sections 4–5. (sec.gov)

Separate delivery from substantive satisfaction. Receiving an officer certificate does not resolve known exceptions to what it certifies. Similarly, identify any diligence cure that the parties actually made a closing requirement rather than importing every open request.

Record: A parent condition row and supporting delivery rows, with precise subsections, beneficiary, and unresolved satisfaction questions.

3. Establish the approval and charter sequence

Compare the issuance with the existing and proposed charter and approval package. Check the security, share numbers, consideration, purchaser allocations, and approved transaction documents. Assign counsel to determine required board, stockholder, class, or contractual consents; do not copy the prior financing’s approval sequence.

For Delaware corporations, DGCL § 152(a) addresses issuance in the numbers, at the times, and for the consideration specified in board resolutions. Section 152(b) requires specified share, time, and minimum-consideration limits for delegated issuance authority. Neither provision alone resolves charter capacity or every necessary approval. See DGCL § 152. (delcode.delaware.gov)

Specify evidence establishing charter effectiveness under the negotiated condition and proposed issuance sequence. A submission acknowledgment is not necessarily that evidence. Check authorized-share headroom against cash issuances, conversions, and other relevant reservations.

Record: Separate approval and charter rows, dependencies, reviewing counsel, and evidence required before release.

4. Reconcile cash purchases, conversions, and share records

Bridge pre-closing capitalization to the purchaser exhibit and proposed post-closing records. Review each SAFE or note under its operative terms, including amendments, principal, applicable interest, conversion mechanics, and rounding. Identify calculation cells and who approves them.

Keep conversion consideration distinct from new cash. Defeye § 1.1(b), for example, separates note-conversion shares from cash-purchase shares with different prices and purchaser allocations. That wording illustrates one structure, not a standard for all rounds. See Defeye, Section 1.1 and Exhibit A. (sec.gov)

Check the model against the ledger without treating them as interchangeable. DGCL § 219(c) describes the stock ledger through record holders, addresses, registered share numbers, and issuance and transfer records—not fully diluted capitalization. (delcode.delaware.gov)

Record: Reconciliation rows identifying instruments, calculation cells, cash obligations, conversion treatment, cancellation or surrender evidence where required, and the stock-record owner.

5. Assemble the signature and certificate package

Prepare a signer matrix from the actual agreements. Match entity names, capacities, signature blocks, exhibits, and joinders; identify side letters separately. Confirm the document version associated with each signature and the instructions governing release.

Before requesting an officer certificate, establish the factual confirmation process. Route known representation or performance changes to counsel. Determine whether updated disclosures are required or permitted under the documents; do not assume a data-room upload is an effective contractual disclosure.

Split signature rows where different signers, documents, or release restrictions create independent blockers. Include any negotiated closing opinion or other delivery only when the operative package requires it.

Record: Signature and certificate rows identifying owner, reviewer, signer or recipient, version, outstanding confirmations, and release restrictions.

6. Run the release review and document exceptions

Hold a focused readiness review using unresolved rows. Confirm charter evidence, approvals, signatures, funding arrangements, conversion treatment, and substantive conditions in the agreed sequence. Record when signatures may be released and when issuance may proceed; those decisions need not be identical.

Verify funding instructions through an independently established contact process. Specify who confirms receipt and preserves evidence. An investor’s payment instruction does not establish receipt.

For each exception, determine whether it needs cure, an authorized waiver, amendment, or another negotiated treatment. Identify the condition beneficiary and authority to agree to the proposed disposition. Do not move an unresolved blocker into “post-closing” merely to clear the list; separately determine whether any legal prerequisite remains unaffected by contractual waiver.

Record: A release-decision row identifying approving counsel, supporting evidence, restrictions, and each exception’s authorized disposition.

7. Preserve completion evidence and hand off surviving tasks

Replace provisional references with final evidence locations. Preserve the completed checklist with the executed package. Hand off stock-record work, agreed undertakings, and filing tasks to accepting owners, with trigger evidence and reviewed deadline calculations.

For offerings under Rules 504 or 506 or Securities Act § 4(a)(5), SEC guidance specifies Form D filing within 15 days after first sale. First sale is the first investor’s irrevocable contractual commitment, which may precede cash receipt; weekend or holiday deadlines move to the next business day. See SEC Form D filing guidance. (sec.gov)

Record: A filing handoff row identifying exemption, actual trigger, calculated deadline, reviewer, and completion proof. Investigate state notices separately; do not assume the federal filing completes the analysis.

Worked example

Fictional scenario: Juniper Harbor Robotics, Inc., a Delaware corporation, proposes a $2.4 million cash seed preferred financing alongside note conversion. All parties, amounts, document references, and contractual terms in this scenario are invented.

PA-07 requires an effective restated charter at the initial closing. Its purchaser exhibit uses a worksheet including note interest, but the supplied amendment addressing interest treatment is unsigned. The filing service has acknowledged charter submission, not effectiveness. Signatures remain held pending release instructions.

The immediate decision changes from “collect the last signature” to “resolve two release blockers and investigate a potentially earlier filing trigger.” C-01 needs better evidence, not necessarily another filing. C-02 needs the operative instrument chain before changing the allocation. H-01 remains open without inventing a commitment date; counsel separately determines its effect on release.

Common mistakes

• Using the term sheet as the controlling source. Extract requirements from operative agreements and approvals; use the term sheet for comparison.
• Treating delivery as satisfaction. Separate certificate receipt from resolution of facts affecting the certified condition.
• Combining conversion and new-money shares. Reconcile instruments, consideration, prices, and allocations separately before checking totals.
• Closing the charter row on submission. Require evidence meeting the effectiveness condition and issuance sequence.
• Reclassifying blockers without authority. Document the cure, authorized waiver, or negotiated change before marking an item resolved.

Final quality check

• Every contractual row cites the verified document version and provision.
• Initial and subsequent closings have distinct requirements and investor lists.
• Approval and charter evidence support the issuance sequence and share capacity.
• Cash, conversions, allocations, and proposed share records reconcile.
• Signatures and certificates match approved versions and release instructions.
• Waivers identify authority, scope, and written evidence.
• Open issues have accepted owners and explicit dispositions; filing tasks identify actual triggers and reviewed deadlines.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. Its contract review supports party-specific instructions, clause-linked findings, severity rankings, and identification of missing language. Lawyers can edit or insert suggestions in Word as ordinary tracked changes in the signed-in user’s name and dismiss findings with reasons. Tabular review supports work across multiple documents. Use these capabilities to inform the lawyer-maintained checklist, not replace closing judgment. Book a demo to discuss reviewing your seed closing package.

Frequently asked questions

Should every diligence request become a closing item?

No. Carry forward requests affecting an actual condition, deliverable, negotiated cure, or release decision. Link the underlying finding rather than duplicate the diligence tracker.

Can one row cover all investor signatures?

Only if it remains independently verifiable. Split rows for different documents, side letters, closing dates, or release restrictions, and retain a signer-level matrix.

What if the note conversion amount is disputed?

Keep reconciliation open, identify competing readings and source instruments, and assign counsel and finance to resolve them. Recheck affected allocations, approvals, and signature versions afterward.

Is the checklist complete when funds arrive?

Not necessarily. Confirm the agreed release sequence and outstanding conditions, preserve evidence, and hand off surviving tasks. As discussed above, the applicable Form D trigger may precede funding.

Sources

• Delaware General Corporation Law § 152.
• Delaware General Corporation Law § 219(c).
• Defeye, Inc., filed Series Seed Preferred Stock Purchase Agreement—drafting example containing a blank execution day, not proof of operative closing terms.
• SEC, Filing a Form D Notice.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.